Q Bio, founded with the mission to build the first universally accessible Clinical Digital Twin Platform, offers innovative health technology solutions. Their core products include the Gemini Digital Twin Platform, which synthesizes digital twins and generates health forecasts, the Mark I full-body scanner, and the Anatomical Foundation Model (AFM) for whole-body radiology. Q Bio aims to revolutionize healthcare by making advanced health diagnostics and monitoring available to everyone.
Notable affiliated individuals and investors include industry experts and leading venture capital firms, though specific names are not provided. Key achievements include the development of the fastest full-body scanner and a foundational AI model for radiology. Q Bio's impact lies in its potential to democratize access to advanced health diagnostics, enabling proactive health management and personalized medical care on a global scale.
